Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4Phase NA 1

Status

Recruiting 8Not yet recruiting 4Completed 4Unknown 2Terminated 1Suspended 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 2Tumor-Agnostic 1

Conditions

Multiple Myeloma 2Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm, Residual 1Neoplasm Metastasis 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × Maintenance × Clear all
NCT03011528 2025-11-21

CombinaiR3

Institut Curie

Phase 2 Completed
45 enrolled

Neuroectodermal Tumors, Primitive, Peripheral

NCT00777998 2023-10-27

Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma

Universitätsklinikum Hamburg-Eppendorf

Phase 2 Completed
221 enrolled
Plasma cell

Multiple Myeloma

NCT02067143 2021-09-08

LAL1913

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 2 Completed
204 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasm, Residual

NCT00580372 2016-09-20

UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma

University of Arkansas

Phase 2 Completed
231 enrolled 6 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡